Abstract
Long known as a spice, cinnamon's potential efficacy in the treatment of type 2 diabetes has been gaining interest. Evidence from animal models shows efficacy as an insulin mimetic and insulin sensitizing agent, in addition to other potential mechanisms of action. Human clinical data regarding its efficacy have shown inconsistent results but may be related to differentials in baseline glucose control, type of cinnamon used, and duration of study. Overall, a significant number of trials have shown cinnamon to be an effective option for lowering blood sugar in uncontrolled type 2 diabetics. Cinnamon's reasonable cost, over-the-counter availability, and safety profile make it a relatively low-risk option for this population.
Original language | English (US) |
---|---|
Pages (from-to) | 23-26 |
Number of pages | 4 |
Journal | American Journal of Lifestyle Medicine |
Volume | 7 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2013 |
All Science Journal Classification (ASJC) codes
- Medicine (miscellaneous)
- Health Policy
- Public Health, Environmental and Occupational Health